Execupharm (India) Private Limited

Execupharm (India) Private Limited - professional services in Bangalore, Karnataka, India. Directors, charges & compliance details.
CIN U73100KA2013PTC067830 Incorporated 12 February 2013 ROC Bangalore HQ Bangalore, Karnataka, India
Struck Off Private Limited Company professional services
Data last updated
Revenue · FY 2017
₹33.41 Lakh
▼ 18% YoY
Net profit · FY 2017
₹4.92 Lakh
Net margin 14.7%
EBITDA · FY 2017
₹9.76 Lakh
EBITDA margin 29.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
GST registrations
1
None active

About Execupharm (India) Private Limited

Data last updated:

Execupharm (India) Private Limited was a private limited company based in Bangalore, Karnataka, India, operated as a subsidiary of Execupharm International Llc, Usa. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the personal services segment of the professional services sector. It was incorporated on 12 February 2013.

The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2013PTC067830. The company has 1 GST registration on record, which is no longer active.

The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Bharamappa Baloj and Suma Valloli Radhakrishna.

Its last annual general meeting (AGM) was held on 05 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at S – 04 1st And 2nd Floor Ibis Hotel 26/1 Hosur Road Bommanahally, Bangalore, Karnataka, India – 560068.

As per the financials filed for FY 2017, the company reported a revenue of ₹33.41 Lakh, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹4.92 Lakh (net margin 14.7%) and EBITDA of ₹9.76 Lakh (EBITDA margin 29.2%).

Company Details of Execupharm (India) Private Limited
CIN U73100KA2013PTC067830
Registration Number 067830
Incorporation Date 12 February 2013
ROC Bangalore
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 05 December 2020
Date of Balance Sheet 31 March 2020
Parent Company Execupharm International Llc, Usa
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    S – 04 1st And 2nd Floor Ibis Hotel 26/1 Hosur Road Bommanahally, Bangalore, Karnataka, India – 560068
  • Industry
    Professional Services, Personal, Scientific, Technical
Comprehensive company report
Execupharm (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Execupharm (India) Private Limited report

Financials, compliance, directors, charges, ownership and filings for Execupharm (India) Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Auditor Details of Execupharm (India) Private Limited

Execupharm (India) Private Limited is audited by Chaturvedi & shah for the financial year 2017.

NameStatusAppointment DateCessation Date
Chaturvedi & shahLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Execupharm (India) Private Limited

Execupharm (India) has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Bharamappa BalojDirector05 Aug 201412 Years 2 MonthsAs last reported
Suma Valloli RadhakrishnaDirector15 Apr 20197 Years 5 MonthsAs last reported

Financials of Execupharm (India) Private Limited FY 2020 filings available

Execupharm (India) Private Limited reported revenue of ₹33.41 Lakh (down 18% YoY) for FY 2017.

Revenue · FY 2017
₹33.41 Lakh ▼ 18%
Net profit · FY 2017
₹4.92 Lakh margin 14.7%
EBITDA · FY 2017
₹9.76 Lakh margin 29.2%

Compounded Annual Growth Rate (CAGR) of Execupharm (India) Private Limited

Revenue CAGR growth
1 year
▼ 18%
EBITDA CAGR growth
1 year
▼ 15%

Revenue fell 18% in the latest year. EBITDA fell 15% in the latest year. All are worked out from the filed statements.

Financial Statement Summary of Execupharm (India) Private Limited

MetricsFY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations₹33.41 Lakh••••••••
Other Income••••••••••••
Total Revenue••••••••••••
Cost of Materials Consumed••••••••••••
Employee Benefit Expense••••••••••••
Finance Costs••••••••••••
Depreciation and Amortisation••••••••••••
Other Expenses••••••••••••
Total Expenses••••••••••••
EBITDA₹9.76 Lakh••••••••
Profit Before Tax••••••••••••
Tax Expense••••••••••••
Net Profit (PAT)₹4.92 Lakh••••••••
Balance Sheet
Share Capital••••••••••••
Reserves and Surplus••••••••••••
Net Worth (Total Equity)••••••••••••
Long-term Borrowings••••••••••••
Short-term Borrowings••••••••••••
Trade Payables••••••••••••
Total Liabilities••••••••••••
Fixed Assets••••••••••••
Investments••••••••••••
Inventories••••••••••••
Trade Receivables••••••••••••
Cash and Bank Balance••••••••••••
Total Assets••••••••••••

Financial Ratios of Execupharm (India) Private Limited

MetricsFY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin29.2%••••••••
Net Profit Margin14.7%••••••••
Return on Equity (ROE)••••••••••••
Return on Capital Employed (ROCE)••••••••••••
Return on Assets (ROA)••••••••••••
Liquidity and Debt
Current Ratio••••••••••••
Quick Ratio••••••••••••
Debt-to-Equity Ratio••••••••••••
Interest Coverage Ratio••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••
Receivable Days••••••••••••
Payable Days••••••••••••
Inventory Days••••••••••••
Revenue Growth••••••••••••
Net Profit Growth••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Execupharm (India) are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Execupharm (India) Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Execupharm (India) Private Limited

Execupharm (India) Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Execupharm (India) Private Limited

Employment history and EPFO contributions of people linked to Execupharm (India).

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Execupharm (India) Private Limited

Execupharm (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Execupharm (India) Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Execupharm (India) Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Execupharm (India) Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Execupharm (India) Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Execupharm (India) Private Limited

Activity
05 Dec 2020
Execupharm (India) Private Limited last Annual general meeting of members was held on 05 Dec 2020 as per latest MCA records.
Activity
31 Mar 2020
Execupharm (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Bangalore.
Directors
15 Apr 2019
Suma Valloli Radhakrishna was appointed as a Director on 15 Apr 2019 & has been associated with this company since 7 years 5 months.
Directors
05 Aug 2014
Bharamappa Baloj was appointed as a Director on 05 Aug 2014 & has been associated with this company since 12 years 2 months.
Activity
12 Feb 2013
Execupharm (India) Private Limited was registered on 12 Feb 2013 with Roc Bangalore & aged 13 years 7 months as per MCA records.

Frequently Asked Questions about Execupharm (India) Private Limited

Execupharm (India) has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Execupharm (India) was a private limited company based in Bangalore, Karnataka, India. The company worked in personal, within the professional services industry. It was incorporated on 12 February 2013 and is registered under CIN U73100KA2013PTC067830. The company has been struck off by the Registrar of Companies and is no longer operational.

Execupharm (India) had 2 directors:

The CIN (Corporate Identification Number) of Execupharm (India) is U73100KA2013PTC067830. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Execupharm (India) is at S – 04 1st And 2nd Floor Ibis Hotel 261 Hosur Road Bommanahally, Bangalore, Karnataka, India – 560068.

Execupharm (India) was incorporated on 12 February 2013. It is registered with the Registrar of Companies, Bangalore.

Execupharm (India) reported revenue of ₹33.41 Lakh for FY 2017 (down 18% YoY).

Execupharm (India) has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.

Execupharm (India) reported a net profit of ₹4.92 Lakh (net margin 14.7%) and EBITDA of ₹9.76 Lakh (EBITDA margin 29.2%) for FY 2017, as per its filed financial statements.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available